Filing Details
- Accession Number:
- 0000950170-24-098731
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-19 18:24:46
- Reporting Period:
- 2024-08-16
- Accepted Time:
- 2024-08-19 18:24:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 876343 | Lineage Cell Therapeutics Inc. | LCTX | Biological Products, (No Disgnostic Substances) (2836) | 943127919 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1892397 | Ann Jill Howe | C/O Lineage Cell Therapeutics 2173 Salk Avenue, Suite 200 Carlsbad CA 92008 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2024-08-16 | 10,500 | $0.89 | 10,500 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
